Gapping down
In reaction to disappointing earnings/guidance:
- REZI -37.5% (reports prelim Q3 revenues below consensus and lowers FY19 adj EBITDA guidance; has begun a comprehensive operational and financial review; names Robert Ryder as interim CFO), IRBT -19.1%, CADE -11.2%, TXN -8.4%, NOW -7.8% (appoints Bill McDermott as CEO, succeeding John Donahoe, who is stepping down to become CEO of Nike (NKE) in January; provides preliminary Q3 results and FY19 financial outlook), HA -6.6%, WHR -5.2%, CSGP -4.4%, SKX -3.7%, RES -2.9%, EEFT -2.8%, SIX -2.6%, LLY -2.6%, WGO -1.8%, CMG -1.7%, LRN -1.4%, CNI -1.2%, BYD -1%, VCYT -0.8%, UCBI -0.8%, WM -0.8%, HLT -0.6%
Select semiconductor/related names showing weakness:
- ON -4.4%, MXIM -4%, ADI -3.3%, MCHP -3%, SWKS -2.8%, MRVL -2.5%, SMH -2.1%, SOXX -1.9%, AVGO -1.9%, NVDA -1.9%, QCOM -1.9%, XLNX -1.8%, AMAT -1.7%, INTC -1.6%, MU -1.5%, AMD -1.5%, TSM -1.3%, LRCX -1.3%, STM -0.9%
Select NOW peers trading lower:
- WDAY -2%, CRM -1.6%, TWLO -1.6%
Other news:
- MGNX -7.9% (reports top line results from second interim overall survival analysis for Phase 3 SOPHIA study of margetuximab)
- OPK -7.9% (announces proposed public offering of up to $100 mln of shares of its common stock)
- NMFC -2.4% (commences underwritten offering of 8,000,000 shares of its common stock)
Analyst comments:
- WBA -1.7% (downgraded to Neutral from Overweight at JP Morgan)
- KIM -0.7% (downgraded to Equal Weight from Overweight at CapitalOne)